Volume 21, Issue 9 , Pages 781-792, September 2010
Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids☆☆☆
Abstract
Typical omega 3 polyunsaturated fatty acids (n-3 PUFAs) are docosahexaenoic acid and eicosapentaenoic acid in the form of fish oils and α linolenic acid from flaxseed oil. Epidemiological studies suggested the benefits of n-3 PUFA on cardiovascular health. Intervention studies confirmed that the consumption of n-3 PUFA provided benefits for primary and secondary prevention of cardiovascular disease. Evidence from cellular and molecular research studies indicates that the cardioprotective effects of n-3 PUFA result from a synergism between multiple, intricate mechanisms that involve antiinflammation, proresolving lipid mediators, modulation of cardiac ion channels, reduction of triglycerides, influence on membrane microdomains and downstream cell signaling pathways and antithrombotic and antiarrhythmic effects. n-3 PUFAs inhibit inflammatory signaling pathways (nuclear factor-κ B activity) and down-regulate fatty acid (FA) synthesis gene expression (sterol regulatory element binding protein-1c) and up-regulate gene expression involved in FA oxidation (peroxisome proliferator-activated receptor α). This review examines the various mechanisms by which n-3 PUFA exert beneficial effects against CVD.
Keywords: Omega 3 polyunsaturated fatty acids, Cardiovascular disease, Atherosclerosis
To access this article, please choose from the options below
☆ Authors have no undisclosed financial or personal interests in any company or organization connected in any way with the research presented in this article.
☆☆ Reference to a company or product name does not imply approval or recommendation of the product by the US Department of Agriculture to the exclusion of others that may be suitable.
PII: S0955-2863(10)00013-6
doi:10.1016/j.jnutbio.2009.12.004
Published by Elsevier Inc.
Volume 21, Issue 9 , Pages 781-792, September 2010
